Risk of adverse gastrointestinal events from inhaled corticosteroids

Richard A. Hansen, Wanzhu Tu, Jane Wang, Roberta Ambuehl, Clement J. McDonald, Michael D. Murray

Research output: Contribution to journalArticle

12 Scopus citations

Abstract

Study Objective. To determine whether patients prescribed inhaled corticosteroids are at risk for adverse gastrointestinal effects. Design. Retrospective cohort study. Setting. Urban health center with an academic affiliation. Patients. A total of 19,443 adults (mean age 31.8 yrs) with airways disease, defined as a diagnosis of asthma or chronic obstructive pulmonary disease, and who were prescribed both an inhaled corticosteroid and albuterol (7156 patients) or inhaled albuterol alone (12,287 patients) between November 1977 and February 2002. Measurements and Main Results. The frequency of adverse gastrointestinal events in the patients who used inhaled corticosteroids and albuterol was compared with that in the patients who used albuterol alone. Adverse gastrointestinal outcomes included events such as gastritis, ulcers, and bleeding. Cox proportional hazards models were used to determine the risk of adverse events, controlling for possible confounders such as alcohol use or nonsteroidal antiinflammatory drug use. Adverse gastrointestinal events were observed in 461 (6.4%) patients using inhaled corticosteroids and albuterol and in 302 (2.5%) patients using only albuterol. After controlling for potential confounders, patients who used inhaled corticosteroids and albuterol had an increased risk for adverse gastrointestinal events compared with patients who used only inhaled albuterol (hazard ratio [HR] 1.26, 95% confidence interval [CI] 1.02-1.56). A prescription for a spacer device reduced this risk among patients using an inhaled corticosteroid (HR 0.26, 95% CI 0.20-0.34). Conclusion. Patients using inhaled corticosteroids appear to have a slight risk for adverse gastrointestinal events that is mitigated in patients who used a spacer device.

Original languageEnglish (US)
Pages (from-to)1325-1334
Number of pages10
JournalPharmacotherapy
Volume28
Issue number11 PART 1
DOIs
StatePublished - Nov 1 2008

    Fingerprint

Keywords

  • Asthma
  • Gastrointestinal adverse events
  • Inhaled corticosteroids
  • Obstructive airways disease
  • Spacer

ASJC Scopus subject areas

  • Pharmacology (medical)

Cite this